AbbVie
ABBV
#30
Rank
โ‚ฌ278.75 B
Marketcap
157,74ย โ‚ฌ
Share price
-1.87%
Change (1 day)
24.29%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚ฌ130.16 Billion

According to AbbVie's latest financial reports the company's total liabilities are โ‚ฌ130.16 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ112.45 B-0.73%
2022-12-31โ‚ฌ113.28 B-2.13%
2021-12-31โ‚ฌ115.75 B3.57%
2020-12-31โ‚ฌ111.76 B28.69%
2019-12-31โ‚ฌ86.84 B46.54%
2018-12-31โ‚ฌ59.26 B8.25%
2017-12-31โ‚ฌ54.74 B-6.31%
2016-12-31โ‚ฌ58.43 B30.11%
2015-12-31โ‚ฌ44.91 B111.94%
2014-12-31โ‚ฌ21.18 B18.45%
2013-12-31โ‚ฌ17.88 B0.08%
2012-12-31โ‚ฌ17.87 B205.89%
2011-12-31โ‚ฌ5.84 B43.1%
2010-12-31โ‚ฌ4.08 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ120.28 B-7.60%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ72.47 B-44.33%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ58.08 B-55.38%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ78.99 B-39.31%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ33.53 B-74.24%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ11.32 B-91.30%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ56.56 B-56.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ61.35 B-52.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ0.77 B-99.41%๐Ÿ‡บ๐Ÿ‡ธ USA